Mafrix Pharmaceuticals Private Limited

Mafrix Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U24230MH2022PTC389046 Incorporated 23 August 2022 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹32.26 Lakh
▲ 38% YoY
Net loss · FY 2025
₹10.27 Lakh
Net margin -31.8%
EBITDA · FY 2025
-₹9.45 Lakh
EBITDA margin -29.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Mafrix Pharmaceuticals Private Limited

Data last updated:

Mafrix Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 August 2022.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2022PTC389046.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohammed Mursaleen Farooqui and Sajid Rais Shaikh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 17 Floor – Grd Plot – 335 C Nagree Apartment Dharavi Main Road, Mumbai, Maharashtra, India – 400017.

As per the financials filed for FY 2025, the company reported a revenue of ₹32.26 Lakh, a growth of 38% compared to the previous year. For the same year it recorded a net loss of ₹10.27 Lakh (net margin -31.8%) and EBITDA of -₹9.45 Lakh (EBITDA margin -29.3%).

Mafrix Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0157596).

Company details

CIN U24230MH2022PTC389046
Registration Number 389046
Incorporation Date 23 August 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0157596

Recognitions & Rankings of Mafrix Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-19-0157596

Contact details

Mafrix Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.

  • Registered Address
    17 Floor – Grd Plot – 335 C Nagree Apartment Dharavi Main Road, Mumbai, Maharashtra, India – 400017
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Mafrix Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Mafrix Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Mafrix Pharmaceuticals Private Limited, buy the company report.

Financials of Mafrix Pharmaceuticals Private Limited

FY 2025 filings available

Mafrix Pharmaceuticals Private Limited reported revenue of ₹32.26 Lakh (up 38% YoY) for FY 2025.

Revenue · FY 2025
₹32.26 Lakh ▲ 38%
Net loss · FY 2025
₹10.27 Lakh margin -31.8%
EBITDA · FY 2025
-₹9.45 Lakh margin -29.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 38%

Revenue rose 38% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹9.45 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹10.27 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin-29.3%
Net Profit Margin-31.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Mafrix Pharmaceuticals Private Limited, buy the company report.

Board of directors of Mafrix Pharmaceuticals Private Limited

Mafrix Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mohammed Mursaleen FarooquiDirector23 Aug 20224 Years 2 MonthsCurrent
Sajid Rais ShaikhDirector23 Aug 20224 Years 2 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Mafrix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Mafrix Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Mafrix Pharmaceuticals Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Mohd Rizwan Farooqui ceased to be Director on 29 Apr 2025.

AGM
Mafrix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Mohd Rizwan Farooqui ceased to be Director.
Filing
Mafrix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Mohammed Mursaleen Farooqui was appointed as Director.
Appointed
Sajid Rais Shaikh was appointed as Director.
Incorporation
23 Aug 2022
Mafrix Pharmaceuticals Private Limited was registered on 23 Aug 2022 with Roc Mumbai I & aged 4 years 2 months as per MCA records.

Frequently asked questions

Mafrix Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 August 2022 (4+ years old) and is registered under CIN U24230MH2022PTC389046.

Mafrix Pharmaceuticals has 2 current directors:

The latest financial statements of Mafrix Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Mafrix Pharmaceuticals is U24230MH2022PTC389046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Mafrix Pharmaceuticals was incorporated on 23 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.

Mohd Rizwan Farooqui ceased to be Director on 29 Apr 2025. Mohammed Mursaleen Farooqui was appointed as Director on 23 Aug 2022. Sajid Rais Shaikh was appointed as Director on 23 Aug 2022.

Yes, Mafrix Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0157596).

The registered office of Mafrix Pharmaceuticals is at 17 Floor – Grd Plot – 335 C Nagree Apartment Dharavi Main Road, Mumbai, Maharashtra, India – 400017.

Mafrix Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

Mafrix Pharmaceuticals can be reached at its registered office: 17 Floor – Grd Plot – 335 C Nagree Apartment Dharavi Main Road, Mumbai, Maharashtra, India – 400017.